ENT Biotech Solutions
Grosse Pointe Farms, US · Founded 2011 · Michigan corporation
Founders & leadership
JB
Jeffery BrinzaExecutive
OL
Olivier LecerfinExecutive
AR
Andrea Roumell DicksonNamed on SEC filing
CB
C. Barthell DicksonNamed on SEC filing
Board
JB
Jack BallBoard director
GK
Gretchen KnoellBoard director
Reported raises · per SEC filings
Form D private placements$2M disclosed across 2 rounds · 2014–2015
▶$1.1MraisedApr 2016 · 17 investors · Other Health CareRule 506(b)
▶$1.1MraisedApr 2016 · 17 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jack BallDirector
- Andrea Roumell DicksonExecutive Officer, Director, Promoter
- C. Barthell DicksonDirector, Promoter
- Jeffery BrinzaExecutive Officer, Director
- Gretchen KnoellDirector
- Olivier LecerfExecutive Officer
- Offering amount
- $1.8M
- Amount sold
- $1.1M
- Minimum investment
- $11.7K
- First sale
- Mar 2015
- Incorporated
- Corporation, Michigan, 2011
- Federal exemptions
- 06b
▶$940KraisedJul 2014 · 14 investors · Other Health CareRule 506(b)
▶$940KraisedJul 2014 · 14 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Gretchen KnoellDirector
- Jack BallDirector
- Olivier LecerfExecutive Officer
- Andrea Roumell DicksonExecutive Officer, Director, Promoter
- C. Barthell DicksonDirector, Promoter
- Jeffery BrinzaExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $940K
- Minimum investment
- $25K
- First sale
- Mar 2014
- Incorporated
- Corporation, Michigan, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has ENT Biotech Solutions raised?
- ENT Biotech Solutions has disclosed $2M raised across 2 rounds.
- Where is ENT Biotech Solutions headquartered?
- ENT Biotech Solutions is headquartered in Grosse Pointe Farms, US.